The Chemours Company (NYSE:CC) Receives $30.38 Consensus PT from Brokerages

The Chemours Company (NYSE:CCGet Free Report) has been given a consensus rating of “Hold” by the eight analysts that are presently covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year price target among analysts that have updated their coverage on the stock in the last year is $30.38.

A number of analysts have recently commented on the stock. Mizuho assumed coverage on shares of Chemours in a research report on Friday, June 7th. They issued a “neutral” rating and a $25.00 price objective on the stock. BMO Capital Markets raised shares of Chemours from an “underperform” rating to an “outperform” rating and upped their price target for the stock from $19.00 to $34.00 in a research report on Tuesday, April 9th. Finally, UBS Group raised shares of Chemours from a “neutral” rating to a “buy” rating and upped their price target for the stock from $28.00 to $30.00 in a research report on Tuesday, July 9th.

Check Out Our Latest Analysis on CC

Chemours Stock Performance

Shares of CC stock opened at $18.75 on Thursday. The company’s fifty day simple moving average is $23.65 and its 200-day simple moving average is $26.29. The company has a quick ratio of 0.99, a current ratio of 1.61 and a debt-to-equity ratio of 5.26. The firm has a market cap of $2.79 billion, a PE ratio of -8.64 and a beta of 1.80. Chemours has a 12 month low of $15.10 and a 12 month high of $37.49.

Chemours (NYSE:CCGet Free Report) last announced its quarterly earnings data on Thursday, August 1st. The specialty chemicals company reported $0.38 EPS for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.19). The business had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.53 billion. Chemours had a return on equity of 32.93% and a net margin of 2.16%. The business’s revenue for the quarter was down 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.10 EPS. Equities research analysts expect that Chemours will post 1.81 EPS for the current fiscal year.

Chemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 13th. Stockholders of record on Thursday, August 15th will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 5.33%. The ex-dividend date is Thursday, August 15th. Chemours’s payout ratio is presently -46.08%.

Hedge Funds Weigh In On Chemours

Large investors have recently modified their holdings of the stock. Spire Wealth Management grew its stake in shares of Chemours by 32.2% in the first quarter. Spire Wealth Management now owns 1,684 shares of the specialty chemicals company’s stock valued at $44,000 after acquiring an additional 410 shares in the last quarter. Burney Co. grew its stake in Chemours by 0.3% during the first quarter. Burney Co. now owns 197,046 shares of the specialty chemicals company’s stock worth $5,174,000 after buying an additional 601 shares in the last quarter. Treasurer of the State of North Carolina grew its stake in Chemours by 1.0% during the fourth quarter. Treasurer of the State of North Carolina now owns 65,924 shares of the specialty chemicals company’s stock worth $2,079,000 after buying an additional 640 shares in the last quarter. Lavaca Capital LLC grew its stake in Chemours by 2.7% during the first quarter. Lavaca Capital LLC now owns 24,658 shares of the specialty chemicals company’s stock worth $648,000 after buying an additional 641 shares in the last quarter. Finally, Hexagon Capital Partners LLC acquired a new stake in Chemours during the fourth quarter worth about $25,000. 76.26% of the stock is owned by institutional investors.

About Chemours

(Get Free Report

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Further Reading

Analyst Recommendations for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.